Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


7 Am J Dermatopathol
7 BMC Cancer
20 Br J Dermatol
23 Eur J Dermatol
9 Int J Dermatol
1 Intern Med
17 J Dermatol
2 J Invest Dermatol
2 Mycoses
1 N Engl J Med
1 Plast Reconstr Surg
5 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Dermatopathol

    Are There Signs of Enthesitis in Nail Psoriasis? An Immunohistological Study of Nail Psoriasis With and Without Psoriatic Arthritis.
    Am J Dermatopathol. 2022 Dec 7. doi: 10.1097/DAD.0000000000002328.
    PubMed         Abstract available

  2. ELKEEB DM, Hopkins ZH, Bolender CM, Moreno C, et al
    A Single-Institution Cohort Study With Nevi of Special Site: Recurrence, Progression to Melanoma, and Patterns of Management.
    Am J Dermatopathol. 2023;45:28-39.
    PubMed         Abstract available

    Are There Signs of Enthesitis in Nail Psoriasis? An Immunohistological Study of Nail Psoriasis With and Without Psoriatic Arthritis.
    Am J Dermatopathol. 2023;45:40-46.
    PubMed         Abstract available

  4. HALLER CN, Carrillo B, Soldano AC, Keeling BH, et al
    A Case of a Rare Histologic Variant: Cavernous Hemangioma-Like Kaposi Sarcoma.
    Am J Dermatopathol. 2023;45:62-63.
    PubMed         Abstract available

  5. WEBER I, Gloss C, Castillo B, Smith E, et al
    Ponatinib-Associated Cutaneous Eruptions-A Case Series and Review of Clinicopathologic Findings.
    Am J Dermatopathol. 2023;45:64-68.
    PubMed         Abstract available

  6. LOPEZ RIQUELME I, Ayala Blanca M, Vera Casano A
    Indurated Papule on the Vulva of a 10-Year-Old Girl: Answer.
    Am J Dermatopathol. 2023;45:71.

  7. LOPEZ RIQUELME I, Ayala Blanca M, Vera Casano A
    Indurated Papule on the Vulva of a 10-Year-Old Girl: Challenge.
    Am J Dermatopathol. 2023;45:e3.

    BMC Cancer

  8. DRAGVOLL I, Bofin AM, Soiland H, Taraldsen G, et al
    Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer.
    BMC Cancer. 2022;22:1247.
    PubMed         Abstract available

  9. LIANG X, Chen X, Yang Z, Liao Y, et al
    Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
    BMC Cancer. 2022;22:1250.
    PubMed         Abstract available

  10. JIANG C, Xiu Y, Yu X, Qiao K, et al
    Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy.
    BMC Cancer. 2022;22:1249.
    PubMed         Abstract available

  11. DE LA CRUZ-MERINO L, Gion M, Cruz J, Alonso-Romero JL, et al
    Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study.
    BMC Cancer. 2022;22:1258.
    PubMed         Abstract available

  12. PAIK HJ, Kim SJ, Kim KS, Kim Y, et al
    Characteristics and chronologically changing patterns of late-onset breast cancer in Korean women of age >/= 70 years: A hospital based-registry study.
    BMC Cancer. 2022;22:1261.
    PubMed         Abstract available

  13. XU D, Xu N, Sun L, Yang Z, et al
    TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway.
    BMC Cancer. 2022;22:1267.
    PubMed         Abstract available

  14. GORMAN LS, Ruane H, Woof VG, Southworth J, et al
    The co-development of personalised 10-year breast cancer risk communications: a 'think-aloud' study.
    BMC Cancer. 2022;22:1264.
    PubMed         Abstract available

    Br J Dermatol

  15. VERMEER MCSC, Al-Shinnag M, Sillje HHW, Gaytan AE, et al
    A translation re-initiation variant in KLHL24 also causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation.
    Br J Dermatol. 2022;187:1045-1048.
    PubMed         Abstract available

  16. SILVERTHORNE CA, Bowen C, Lord J, McHugh N, et al
    A qualitative study of patients' experiences of screening for psoriatic arthritis.
    Br J Dermatol. 2022;187:1035-1037.

  17. LINDQVIST PG, Epstein E, Landin-Olsson M
    On the potential beneficial effects of indoor tanning.
    Br J Dermatol. 2022;187:1057.

  18. MOSTMANS Y, Smith V, Cutolo M, Melsens K, et al
    Nailfold videocapillaroscopy and serum vascular endothelial growth factor in probable COVID-19-induced chilblains: a cross-sectional study to assess microvascular impairment.
    Br J Dermatol. 2022;187:1017-1019.

  19. MATARD B, Bourrat E, Cavalie M, Chiaverini C, et al
    Folliculitis decalvans and dystrophic epidermolysis bullosa: a significant association.
    Br J Dermatol. 2022;187:1026-1028.
    PubMed         Abstract available

  20. JI-XU A, Lei DK, Worswick S, Maloney NJ, et al
    Patient and disease characteristics associated with psychiatric symptoms and impaired quality of life in pityriasis rubra pilaris.
    Br J Dermatol. 2022;187:1024-1026.

  21. KOPTYEV J, Strunk A, Garg A
    Low predictive value of questionnaire-based diagnosis of hidradenitis suppurativa.
    Br J Dermatol. 2022;187:1015-1017.

  22. COOK MK, Perche PO, White JC, Feldman SR, et al
    Psychosocial burden of frontal fibrosing alopecia: a qualitative interview study.
    Br J Dermatol. 2022;187:1013-1015.

  23. LIU Q, Tang Y, Huang Y, Wang J, et al
    Insights into male androgenetic alopecia using comparative transcriptome profiling: hypoxia-inducible factor-1 and Wnt/beta-catenin signalling pathways.
    Br J Dermatol. 2022;187:936-947.
    PubMed         Abstract available

  24. GABES M, Ragamin A, Baker A, Kann G, et al
    Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study.
    Br J Dermatol. 2022;187:919-926.
    PubMed         Abstract available

  25. LIU J, Chen Z, Hu L, Song Z, et al
    Three new founder mutations in Chinese patients with Nagashima-type palmoplantar keratoderma.
    Br J Dermatol. 2022;187:1043-1045.

  26. REHMAN R, Haque M, Ceresnie M, Hamzavi IH, et al
    Dermatological considerations and culturally sensitive recommendations for women who wear the hijab.
    Br J Dermatol. 2022;187:1003-1004.
    PubMed         Abstract available

  27. CAPOZZA K, Vastrup A, Proctor A, Roberts A, et al
    The sound of silence: where are the voices of patients in eczema guideline development?
    Br J Dermatol. 2022;187:1005-1006.

  28. MIDGETTE B, Strunk A, Akilov O, Alavi A, et al
    Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
    Br J Dermatol. 2022;187:927-935.
    PubMed         Abstract available

  29. EDEN M, Hainsworth R, Gordon LG, Epton T, et al
    On the potential beneficial effects of indoor tanning: reply from the authors.
    Br J Dermatol. 2022;187:1057-1058.

  30. KRIDIN K, Hammers CM
    Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid.
    Br J Dermatol. 2022;187:843-844.

  31. LAX SJ, Drucker AM
    How will brepocitinib cream compare with established treatments for mild-to-moderate eczema?
    Br J Dermatol. 2022;187:838.

    Transcriptomic analysis identifies regulators of the Wnt signalling and hypoxia-inducible factor pathways as possible mediators of androgenetic alopecia.
    Br J Dermatol. 2022;187:845.

  33. A review of how pain is measured in painful skin conditions and rheumatoid arthritis studies, to determine pain measurement in future hidradenitis suppurativa trials.
    Br J Dermatol. 2022;187:e196-e221.

  34. MROWIETZ U, Augustin M
    Using the upgrade criteria of the European Psoriasis Consensus is best practice care according to the people-centred healthcare concept of the World Health Organization.
    Br J Dermatol. 2022;187:1007-1008.

    Eur J Dermatol

  35. ZHANG N, Feng J, Gu L, Zhang W, et al
    A case of multiple juvenile xanthogranuloma with unusual clinicopathological features.
    Eur J Dermatol. 2022;32:643-645.

  36. SHIN MK, Seo JI
    Nonavalent human papillomavirus vaccine for cutaneous warts: a retrospective study.
    Eur J Dermatol. 2022;32:642-643.

  37. FUJISHIMA C, Hioki C, Sasaki H, Yoshida H, et al
    A case of Bazex syndrome with type 2 immune response.
    Eur J Dermatol. 2022;32:641-642.

  38. TIOTIU A, Jaussaud R
    Successful treatment with omalizumab for cold urticaria in a patient with chronic hepatitis C virus infection.
    Eur J Dermatol. 2022;32:640-641.

  39. HONDA KEITH Y, Yamauchi I, Yamane S, Inagaki N, et al
    Hypothyroidism associated with povidone-iodine sugar ointment for chronic cutaneous ulcers.
    Eur J Dermatol. 2022;32:638-640.

  40. CAPURRO N, Trave I, Cozzani E, Gasparini G, et al
    Post-surgery morphea mimicking relapse of breast cancer.
    Eur J Dermatol. 2022;32:637-638.

  41. ZHONG L, Song Y, Hu J, Yao X, et al
    Successful treatment of disseminated amphotericin-resistant fusariosis in a paediatric patient with acute lymphoblastic leukaemia: a case report and literature review.
    Eur J Dermatol. 2022;32:623-628.
    PubMed         Abstract available

  42. LIANG B, Meng D, Cao Y, Zhang D, et al
    A novel splice-site variant of the LAMB3 gene is associated with junctional epidermolysis bullosa.
    Eur J Dermatol. 2022;32:632-636.
    PubMed         Abstract available

  43. HUANG S, Yang Y, Ouyang Z, Guo X, et al
    The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata.
    Eur J Dermatol. 2022;32:589-596.
    PubMed         Abstract available

  44. FUKUI M, Shiraishi K, Yoshida S, Yatsuzuka K, et al
    Olaparib-induced cutaneous vasculitis in a patient with recurrent ovarian cancer.
    Eur J Dermatol. 2022;32:655-656.

  45. SPURNY-DWORAK J, Steiner A, Breier F, Stella A, et al
    Effects of the COVID-19 pandemic on the diagnosis of malignant melanoma: a retrospective study.
    Eur J Dermatol. 2022;32:615-617.
    PubMed         Abstract available

  46. MOLINELLI E, Sapigni C, Simonetti O, Brisigotti V, et al
    Successful use of dalbavancin in the management of severe hidradenitis suppurativa.
    Eur J Dermatol. 2022;32:645-646.

  47. LI Y, Yu Y, Wang Y, Lu J, et al
    Ixekizumab four-week dosing is comparable to two-week dosing in psoriasis patients and reduces treatment costs: experience in a real-world setting over a 12-week period.
    Eur J Dermatol. 2022;32:618-622.
    PubMed         Abstract available

  48. BAEK YS, Kim YC, Kim KE, Jeon J, et al
    Low detection rate of human papillomavirus in patients with cutaneous squamous cell carcinoma and keratoacanthoma.
    Eur J Dermatol. 2022;32:577-583.
    PubMed         Abstract available

  49. SALONEN J, Remitz A, Salonen J, Lauerma A, et al
    Allergic conjunctivitis: a risk factor for recurrent herpes simplex virus infections in patients with atopic dermatitis.
    Eur J Dermatol. 2022;32:607-614.
    PubMed         Abstract available

  50. MELE-NINOT G, Serra-Baldrich E, Spertino J, Guilarte M, et al
    Are antihistamines still used during omalizumab treatment for chronic spontaneous urticaria?
    Eur J Dermatol. 2022;32:629-631.
    PubMed         Abstract available

  51. STEFANOU G, Gregoriou S, Kontodimas S, Sfaelos K, et al
    Prevalence of adult self-reported atopic dermatitis in Greece: results from a nationwide survey.
    Eur J Dermatol. 2022;32:597-606.
    PubMed         Abstract available

  52. PIGNE T, Amico S, Vargas F, Pham-Ledard A, et al
    Bilateral breast necrosis, post-coronary artery bypass grafting, treated by hyperbaric oxygen therapy.
    Eur J Dermatol. 2022;32:648-649.

  53. HONDA R, Suenaga A, Nakahara T, Shibata-Kikuchi S, et al
    Atopic dermatitis refractory to dupilumab but markedly responsive to baricitinib.
    Eur J Dermatol. 2022;32:649-650.

  54. TANAKA H, Ishii N, Koga H, Izumi K, et al
    Linear immunoglobulin A bullous dermatosis complicating ulcerative colitis after a missed abortion.
    Eur J Dermatol. 2022;32:656-658.

  55. ROSELL DIAZ A, Lefevre MA, Mohme S, Alband N, et al
    Journal Club: Cutaneous squamous cell carcinoma.
    Eur J Dermatol. 2022;32:660-662.

  56. MOHME S, Goebeler M, Wohlleben M, Hamm H, et al
    A blistering child: sudden erythema with blisters in a sick girl.
    Eur J Dermatol. 2022;32:663-665.

  57. NI Y, Fang M, Wu B
    sQuiz your knowledge! Osteoarthritis in an adolescent with acne.
    Eur J Dermatol. 2022;32:665-667.

    Int J Dermatol

  58. AROMOLO IF, Maronese CA, Bortoluzzi P, Marzano A, et al
    Primary macroglobulinemia-induced immunobullous dermatosis: A systematic review.
    Int J Dermatol. 2022 Dec 2. doi: 10.1111/ijd.16546.

  59. ZOU H, Daveluy S
    Linear IgA bullous dermatosis after COVID-19 vaccination.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16541.

  60. SMITH B, Oulee A, Devjani S, Collier MR, et al
    Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016-2020.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16545.

  61. HODELIN C, Fan R, Damsky W, Cohen JM, et al
    The association of atopic dermatitis and chronic rhinosinusitis in adults: a cross-sectional study using the All of Us research program.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16544.

  62. HENG LW, Cheng SWN
    Potential pitfalls of odontogenic cutaneous sinus tract.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16533.

  63. EVENSON CJ, Rosenbach M, Shields BE
    Utility of angiotensin-converting enzyme and serum calcium levels in cutaneous sarcoidosis.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16547.
    PubMed         Abstract available

    A cross-sectional analysis of Google images of mycosis fungoides: is dark skin adequately represented?
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16537.

  65. AHMAD M, Murphy MJ, Damsky W, Leventhal J, et al
    Dupilumab-induced psoriasis in the setting of pembrolizumab therapy: an analysis of cytokine expression.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16538.

  66. SOLAK B, Aydin B, Yuksekal G, Yaldiz M, et al
    Restless legs syndrome in patients with psoriasis: association with inflammation and sleep quality.
    Int J Dermatol. 2022 Dec 5. doi: 10.1111/ijd.16532.
    PubMed         Abstract available

    Intern Med

  67. ONOKI T, Metoki T, Iwasawa S, Kawano K, et al
    Two Distinct Cases of Adult-onset Kawasaki Disease.
    Intern Med. 2022;61:3525-3529.
    PubMed         Abstract available

    J Dermatol

  68. ZHANG Z, Yu K, Jiang Z, Liu O, et al
    Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Dec 7. doi: 10.1111/1346-8138.16661.
    PubMed         Abstract available

  69. KINOSHITA Y, Tateishi C, Sowa-Osako J, Kusutani N, et al
    Generalized granuloma annulare with large patches on the face.
    J Dermatol. 2022;49:e426-e427.

  70. UCHIYAMA A, Kosaka K, Okada K, Motegi SI, et al
    Possible suppressive effects of tranilast on NLRP3 inflammasome activation in necrobiosis lipoidica.
    J Dermatol. 2022;49:e433-e434.

  71. SEISHIMA M, Sasaki M, Sugie S
    Successful treatment of pyoderma gangrenosum using adalimumab in a patient undergoing hemodialysis.
    J Dermatol. 2022;49:e435-e436.

  72. MINAMI Y, Okamoto T, Hirotsu Y, Amemiya K, et al
    Phakomatosis pigmentovascularis type IIb with Klippel-Trenaunay syndrome: Association with GNAQ mutation in vascular endothelial cells.
    J Dermatol. 2022;49:e444-e445.

  73. IKEDA T, Yokoyama K, Kawakami T
    Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
    J Dermatol. 2022;49:e446-e447.

  74. XU X, Pradhan S, Zhang C, Ran Y, et al
    A case of infantile tinea of vellus hair confirmed by dermoscopy and scanning electron microscopy and detection of infected source.
    J Dermatol. 2022;49:1325-1329.
    PubMed         Abstract available

  75. YANG J, Zeng J, Lu J
    Mechanisms of ultraviolet-induced melasma formation: A review.
    J Dermatol. 2022;49:1201-1210.
    PubMed         Abstract available

  76. HIRAIWA T, Yamamoto T
    Survey of the treatment outcome of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    J Dermatol. 2022;49:e448.

  77. KASHIWADA-NAKAMURA K, Noguchi H, Hiruma M, Tanaka M, et al
    Dermoscopic findings of sporotrichosis manifesting as a punched-out ulcer.
    J Dermatol. 2022;49:e449-e450.

  78. SANCHEZ-DIAZ M, Salvador-Rodriguez L, Cuenca-Barrales C, Arias-Santiago S, et al
    Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study.
    J Dermatol. 2022;49:1238-1244.
    PubMed         Abstract available

  79. SAITO R, Takahagi S, Nakano F, Furutani K, et al
    A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.
    J Dermatol. 2022;49:1255-1262.
    PubMed         Abstract available

  80. HASEGAWA T, Oyama N, Kasamatsu H, Chino T, et al
    Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
    J Dermatol. 2022;49:e453-e454.

  81. NISHIBU A, Iwanaga T, Ushigami T, Mochizuki T, et al
    A case of hidrotic ectodermal dysplasia with developing eccrine syringofibroadenoma with heterozygous mutation of GJB6 gene.
    J Dermatol. 2022;49:e451-e452.

  82. KIKUCHI K, Katsuyama M, Yoshikawa T, Wakeshima N, et al
    Epidemiological survey of the quantity and anatomical position of facial pigmented spots in relation to age in 454 Japanese women.
    J Dermatol. 2022;49:1245-1254.
    PubMed         Abstract available

  83. WALKER AM, Bermas BL, Jacobe HT
    Morphea disease activity during pregnancy: A case series.
    J Dermatol. 2022;49:1278-1283.
    PubMed         Abstract available

  84. YAMASAKI K, Miyachi Y
    Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan.
    J Dermatol. 2022;49:1221-1227.
    PubMed         Abstract available

    J Invest Dermatol

  85. MORISAKA H, Takaishi M, Akira S, Sano S, et al
    Keratinocyte Regnase-1, a down-regulator of skin inflammation, contributes to protection against tumor promotion by limiting COX-2 expression.
    J Invest Dermatol. 2022 Dec 2:S0022-202X(22)02827.
    PubMed         Abstract available

  86. BORGOGNA C, Martuscelli L, Olivero C, Lo Cigno I, et al
    Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed HPV8 Transgenic Mice.
    J Invest Dermatol. 2022 Dec 5:S0022-202X(22)02829.
    PubMed         Abstract available


  87. BATVANDI A, Pchelin IM, Kiasat N, Kharazi M, et al
    Time and cost-efficient identification of Trichophyton indotineae.
    Mycoses. 2023;66:75-81.
    PubMed         Abstract available

  88. MOSELEY I, Ragi SD, Ouellette S, Rao B, et al
    Tinea pedis in underrepresented groups: All of Us database analysis.
    Mycoses. 2023;66:29-34.
    PubMed         Abstract available

    N Engl J Med

  89. ROHAAN MW, Borch TH, van den Berg JH, Met O, et al
    Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2022;387:2113-2125.
    PubMed         Abstract available

    Plast Reconstr Surg

  90. SOARES DJ, Bowhay A, Blevins LW, Patel SM, et al
    "Patterns of filler-induced facial skin necrosis: A systematic review of 243 cases and introduction of the F.O.E.M. scoring system and grading scale.".
    Plast Reconstr Surg. 2022 Dec 6. doi: 10.1097/PRS.0000000000009991.
    PubMed         Abstract available

    PLoS One

  91. JACKSON C, Finikarides L, Freeman ALJ
    The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
    PLoS One. 2022;17:e0275321.
    PubMed         Abstract available

  92. MUKAMI A, Juma BS, Mweu C, Ngugi M, et al
    Plant regeneration from leaf mesophyll derived protoplasts of cassava (Manihot esculenta Crantz).
    PLoS One. 2022;17:e0278717.
    PubMed         Abstract available

  93. LANKREW AYALEW T, Wale BG, Haile KE, Zewudie BT, et al
    Health-related quality of life and associated factors among cancer patients in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0277839.
    PubMed         Abstract available

  94. LUO J, Chen S, Chen J, Zhou Y, et al
    Identification and validation of DNA methylation markers to predict axillary lymph node metastasis of breast cancer.
    PLoS One. 2022;17:e0278270.
    PubMed         Abstract available

  95. SCHWARZ F, Arefian H, Hartmann M, Runnebaum I, et al
    Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
    PLoS One. 2022;17:e0278460.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  96. LIN WC, Lin FT
    Super-enhanced MARCO variant drives triple-negative breast cancer progression.
    Proc Natl Acad Sci U S A. 2022;119:e2217953119.

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.